WHOOP, the human performance company, has successfully closed a $575 million Series G funding round, elevating its valuation to a remarkable $10.1 billion. The investment was led by Collaborative Fund and attracted a diverse coalition of global investors, including sovereign wealth funds, prominent health institutions, and elite athletes. This capital infusion marks a pivotal moment for the company as it advances its mission to redefine personalized health technology on a global scale.
A Landmark Investment for Human Performance
The funding round saw significant participation from major entities such as 2PointZero Group, Qatar Investment Authority, and Mubadala Investment Company. This new valuation represents a nearly threefold increase from its previous $3.6 billion figure, signaling immense investor confidence in WHOOP's market position and future trajectory. The substantial capital injection, which brings total funding to approximately $900 million, will further solidify the company's leadership in the wearable technology sector.
Fueling Global Expansion and Growth
This financing follows a period of extraordinary growth, with the company reporting a 103% year-over-year increase in bookings for 2025. WHOOP exited the year with a $1.1 billion run rate and operated with positive cash flow, now serving a rapidly growing base of over 2.5 million members. The company plans to hire over 600 new employees to support its expansion into Europe, the GCC, Latin America, and Asia.
Strategic Alliances in Healthcare
A key strategic development is the investment from global healthcare leader Abbott and the renowned Mayo Clinic. This partnership underscores WHOOP's deliberate shift from a fitness-focused device to an integral tool for preventive and personalized healthcare. The collaboration aims to merge continuous biometric monitoring with established medical expertise to predict risk and improve long-term health outcomes for users.
The Vision for a Personalized Health Platform
CEO Will Ahmed emphasized that the funding unites investors behind the mission to unlock human performance and extend healthspan in an era of rising chronic disease. The platform utilizes over 24 billion hours of physiological data and purpose-built AI models to deliver predictive, personalized health insights. High user engagement, with members accessing the app over eight times daily, highlights the platform's essential role in their daily routines.
The round also includes investments from iconic athletes like Cristiano Ronaldo, LeBron James, and Rory McIlroy, reinforcing the brand's elite status. Ronaldo, now an investor and global ambassador, praised WHOOP as one of the most important tools he uses for supporting his long-term health. This powerful endorsement from top performers underscores the deep connection between the platform and achieving peak human performance.
With this significant capital, WHOOP is strongly positioned to accelerate its global presence and solidify its platform as a new standard in preventive health. While the company is undertaking the necessary preparations for a potential future public offering, its immediate focus remains on product innovation and international expansion. This funding round is a clear endorsement of its vision to empower individuals everywhere to take proactive control of their health and well-being.